Contents

Search

sublingual dust mite extract/immunotherapy (Odactra)

Indications: - allergic rhinitis &/or conjunctivitis due to dust mites (Odactra FDA-approved March 2017) Dosage: - sublingual once daily year round - may take 8-14 weeks before benefits observed [2]

General

sublingual allergen extract dust mite extract

References

  1. Bergmann K-C et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol 2014 Jun; 133:1608 PMID: 24388010 http://www.jacionline.org/article/S0091-6749%2813%2901773-9/abstract
  2. Brown T Odactra First Sublingual Therapy OK'd for House Dust Mite Allergy. Medscape. Mar 01, 2017 http://www.medscape.com/viewarticle/876513 - FDA News Release. March 1, 2017 FDA approves Odactra for house dust mite allergies. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm544330.htm